Abstract:Introduction Increased expression of αv integrins is frequently associated with tumor cell adhesion, migration, invasion and metastasis, and correlates with poor prognosis in breast cancer. However, the mechanism by which αv integrins can enhance breast cancer progression is still largely unclear. The effects of therapeutic targeting of αv integrins in breast cancer also have yet to be investigated. Methods We knocked down αv integrin in MDA-MB-231 and MCF10A-M4 breast cancer cells, or treated these cells with the αv antagonist GLPG0187. The effects of αv integrin depletion on mesenchymal markers, transforming growth factor-β (TGF-β)/Smad signaling and TGF-β-induced target gene expression were analyzed in MDA-MB-231 cells by RNA analysis or Western blotting. The function of αv integrin on breast cancer cell migration was investigated by transwell assay in vitro , and its effect on breast cancer progression was assessed by both zebrafish and mouse xenografts in vivo . In the mouse model, GLPG0187 was administered separately, or in combination with the standard-of-care anti-resorptive agent zoledronate and the chemotherapeutic drug paclitaxel, to study the effects of combinational treatments on breast cancer metastasis. Results Genetic interference and pharmacological targeting of αv integrin with GLPG0187 in different breast cancer cell lines inhibited invasion and metastasis in the zebrafish or mouse xenograft model. Depletion of αv integrin in MDA-MB-231 cells inhibited the expression of mesenchymal markers and the TGF-β/Smad response. TGF-β induced αv integrin mRNA expression and αv integrin was required for TGF-β-induced breast cancer cell migration. Moreover, treatment of MDA-MB-231 cells with non-peptide RGD antagonist GLPG0187 decreased TGF-β signaling. In the mouse xenografts GLPG0187 inhibited the progression of bone metastasis. Maximum efficacy of inhibition of bone metastasis was achieved when GLPG0187 was combined with the standard-of-care metastatic breast cancer treatments. Conclusion These findings show that αv integrin is required for efficient TGF-β/Smad signaling and TGF-β-induced breast cancer cell migration, and for maintaining a mesenchymal phenotype of the breast cancer cells. Our results also provide evidence that targeting αv integrin could be an effective therapeutic approach for treatment of breast cancer tumors and/or metastases that overexpress αv integrin.

Adhesion of Wild Type and Integrin Signaling Defective Mammary Tumor Cells to Microvascular Endothelium in Vivo

Effects of integrin signaling on mammary tumor cells adhesion to microvascular endothelium in vivo

Intracrine Vegf Signalling Mediates Colorectal Cancer Cell Migration and Invasion

Vascular Endothelial Growth Factor Enhances Cancer Cell Adhesion to Microvascular Endothelium in Vivo

Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA.

Elucidation of the Roles of Tumor Integrin β1 in the Extravasation Stage of the Metastasis Cascade

Roles for GP IIb/IIIa and Αvβ3 Integrins in MDA-MB-231 Cell Invasion and Shear Flow-Induced Cancer Cell Mechanotransduction

Quantification of Malignant Breast Cancer Cell MDA-MB-231 Transmigration Across Brain and Lung Microvascular Endothelium

Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models

Effects of integrin αvβ6 on endo-exocytotic cycle of integrin αvβ5 in colon cancer cells

Platelets Promote Breast Cancer Cell MCF-7 Metastasis by Direct Interaction: Surface Integrin Alpha 2 Beta 1-Contacting-mediated Activation of Wnt-beta-catenin Pathway

Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function

The Role of Adhesion Molecules, Alpha V Beta 3, Alpha V Beta 5 and Their Ligands in the Tumor Cell and Endothelial Cell Adhesion

The Effects of αvβ3 Integrin Blockage in Breast Tumor and Endothelial Cells under Hypoxia In Vitro

Defining Integrin Tension Required for Chemotaxis of Metastatic Breast Cancer Cells in Confinement

Integrin Affinity Modulation in Angiogenesis.

Abstract 19483: Vitronectin Increases Vascular Permeability by Promoting Ve-Cadherin Internalization at Cell Junctions

Positive Regulation of Cell Migration and Invasion by VASP Via Rac1 Pathway in Human Mammary Epithelial Cells

Integrin signaling is critical for pathological angiogenesis.

Vitronectin Increases Vascular Permeability by Promoting Ve-Cadherin Internalization at Cell Junctions

In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix